Sofiva GenomicsLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Sofiva GenomicsLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 18.7% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Some Investors May Be Worried About Sofiva GenomicsLtd's (GTSM:6615) Returns On Capital
Apr 14Estimating The Fair Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Mar 18Sofiva Genomics Co.,Ltd. (GTSM:6615) Investors Should Think About This Before Buying It For Its Dividend
Feb 24Should Weakness in Sofiva Genomics Co.,Ltd.'s (GTSM:6615) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 27Our Take On The Returns On Capital At Sofiva GenomicsLtd (GTSM:6615)
Jan 07A Look At The Intrinsic Value Of Sofiva Genomics Co.,Ltd. (GTSM:6615)
Dec 15Read This Before Buying Sofiva Genomics Co.,Ltd. (GTSM:6615) For Its Dividend
Nov 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sofiva GenomicsLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 465 | 21 | -1 | 24 | N/A |
6/30/2024 | 478 | 25 | -23 | 3 | N/A |
3/31/2024 | 475 | 20 | -18 | 6 | N/A |
12/31/2023 | 467 | 12 | -1 | 24 | N/A |
9/30/2023 | 472 | 34 | -7 | 19 | N/A |
6/30/2023 | 473 | 31 | -30 | 14 | N/A |
3/31/2023 | 483 | 33 | -24 | 12 | N/A |
12/31/2022 | 496 | 43 | -19 | 17 | N/A |
9/30/2022 | 501 | 37 | 7 | 42 | N/A |
6/30/2022 | 506 | 49 | 60 | 79 | N/A |
3/31/2022 | 510 | 62 | 71 | 86 | N/A |
12/31/2021 | 508 | 57 | 67 | 80 | N/A |
9/30/2021 | 507 | 53 | 74 | 88 | N/A |
6/30/2021 | 505 | 44 | 77 | 85 | N/A |
3/31/2021 | 494 | 33 | 64 | 72 | N/A |
12/31/2020 | 489 | 35 | 45 | 61 | N/A |
9/30/2020 | 489 | 37 | 29 | 50 | N/A |
6/30/2020 | 497 | 48 | 28 | 50 | N/A |
3/31/2020 | 506 | 59 | 51 | 77 | N/A |
12/31/2019 | 509 | 63 | 78 | 101 | N/A |
9/30/2019 | 504 | 61 | 75 | 97 | N/A |
6/30/2019 | 486 | 51 | 71 | 98 | N/A |
3/31/2019 | 469 | 49 | 47 | 73 | N/A |
12/31/2018 | 459 | 47 | 26 | 54 | N/A |
9/30/2018 | 451 | 46 | 29 | 58 | N/A |
6/30/2018 | 446 | 48 | N/A | 49 | N/A |
3/31/2018 | 438 | 45 | N/A | 50 | N/A |
12/31/2017 | 424 | 45 | N/A | 66 | N/A |
9/30/2017 | 410 | 48 | N/A | 75 | N/A |
6/30/2017 | 398 | 49 | N/A | 102 | N/A |
3/31/2017 | 388 | 45 | N/A | 87 | N/A |
12/31/2016 | 384 | 43 | N/A | 66 | N/A |
6/30/2016 | 373 | 33 | N/A | 14 | N/A |
3/31/2016 | 356 | 25 | N/A | 12 | N/A |
12/31/2015 | 344 | 16 | N/A | 13 | N/A |
12/31/2014 | 295 | 23 | N/A | 22 | N/A |
12/31/2013 | 154 | -23 | N/A | -11 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 6615's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if 6615's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 6615's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 6615's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 6615's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6615's Return on Equity is forecast to be high in 3 years time